The path to ME/CFS diagnosis: the Canadian Consensus Criteria explained, and how objective daily data can strengthen the conversation with your doctor
Roughly 90 percent of people with ME/CFS in Germany remain undiagnosed. Learn what the Canadian Consensus Criteria actually require for diagnosis, and how wearable trends can support the conversation with your doctor.
On this page
If you have been exhausted for years and been told it is "just stress," "burnout depression," or that you should "exercise more" - you are not alone, and that is not a coincidence. The German Society for ME/CFS estimates that roughly 90 percent of people with ME/CFS in Germany do not have a diagnosis. This is not a minor footnote; it is the central healthcare access problem for this condition. Sam cannot give you a diagnosis - but it can show you, for free, the everyday data that can become the foundation for a conversation with your doctor.
A disease long overlooked
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) is not new - it has existed for decades - but it has been neglected and misunderstood in the German healthcare system for a long time. Many patients were, and still are, wrongly classified as having a psychiatric or psychosomatic illness, even though the WHO classifies ME/CFS as a neurological disorder (ICD-10 G93.3). No laboratory biomarker has been identified yet; diagnosis relies on clinical criteria such as the Canadian Consensus Criteria.
The result: according to the German Society for ME/CFS, an estimated 90 percent of people with ME/CFS in Germany go without a diagnosis. Current estimates put the number of people with ME/CFS in Germany at 500,000 to over 600,000, with a sharp rise since the COVID-19 pandemic, as some long COVID patients meet the diagnostic criteria for ME/CFS.
If you have felt unheard for years: that is not about you. It reflects a healthcare system that has misunderstood this condition for too long.
The Canadian Consensus Criteria for ME/CFS diagnosis
In German-speaking countries, ME/CFS specialists predominantly recommend the Canadian Consensus Criteria (CCC) - used for example at specialized centres like the Charité Fatigue Center in Berlin. Core requirements include:
- Post-exertional malaise (PEM) as the central symptom
- Symptom duration of at least six months in adults (three months in children)
- Additional symptoms from multiple domains, such as sleep disturbance, pain, cognitive problems, and symptoms of autonomic or neuroendocrine dysfunction
Technically any physician can apply these established criteria. However, because many general practitioners are unfamiliar with the Canadian Criteria, evaluation at a specialized centre such as the Charité Fatigue Center is often recommended. The structured diagnostic interview alone takes roughly one hour - the complete diagnostic workup including exclusion testing often stretches across multiple appointments over weeks.
Why objective data can strengthen the conversation
A recurring pattern in ME/CFS is that symptoms like exhaustion, dizziness, or "brain fog" remain invisible from the outside and are therefore questioned. Objective data collected over weeks - resting heart rate trend, sleep quality, activity patterns - can carry a different kind of weight here than descriptions alone: it is observable and harder to dismiss as "just in your head."
This does not replace structured diagnosis using the Canadian Criteria. But a concrete report of your recent weeks can help put the conversation on more equal footing - especially if you feel your memory alone doesn't give you enough to go on.
Where Sam Health fits in
Sam reads resting heart rate, sleep, and activity from Apple Health and summarizes them monthly in a report - concrete weeks instead of vague memories. This can help you prepare for your next doctor appointment, but it does not replace the structured diagnostic workup using the Canadian Consensus Criteria. To understand orthostatic intolerance and how a standing test differs from Sam's passive tracking, see the article Standing heart rate and orthostatic intolerance in ME/CFS.
Try Sam HealthDisclaimer
Sam is a wellness companion, not a medical device. Sam does not diagnose, treat, or prevent ME/CFS and does not replace medical diagnostics. If you suspect you have ME/CFS, consult a doctor, ideally one with experience in ME/CFS care.
Sources
- German Society for ME/CFS: Data & Facts
- German Society for ME/CFS: Frequently Asked Questions
- Charité Fatigue Center: Diagnostic Criteria for ME/CFS
- ME/CFS Freiburg: The Situation in Germany
Frequently Asked Questions
Why does it take so long to get an ME/CFS diagnosis in Germany?+
ME/CFS has been neglected and misunderstood in the German healthcare system for decades - patients are often wrongly categorized as having a psychiatric or psychosomatic condition. A substantial share of cases are believed to go undiagnosed, with some estimates as high as roughly 90 percent - though an exact figure cannot be reliably determined when so many cases go unrecognized.
What diagnostic criteria are used for ME/CFS?+
In German-speaking countries, ME/CFS specialists predominantly recommend the Canadian Consensus Criteria (CCC), also used at specialized centres like the Charité Fatigue Center in Berlin. A diagnosis requires symptom duration of at least six months in adults (three months in children), with post-exertional malaise (PEM) as the central feature.
Who can diagnose ME/CFS?+
Technically any physician can apply the clinical criteria. However, since many general practitioners are unfamiliar with the Canadian Criteria, professional bodies such as the German Society for ME/CFS and specialized centres such as the Charité Fatigue Center often recommend evaluation there instead. The structured diagnostic interview alone takes roughly one hour, and the complete workup including exclusion testing typically spans multiple appointments over several weeks.
How common is ME/CFS in Germany?+
Estimates vary widely: current figures put the number of people with ME/CFS in Germany at 500,000 to over 600,000, with a marked upward trend since the COVID-19 pandemic. Women are affected roughly three times more often than men, with onset peaks in the teenage years and in the mid-thirties.